Family · Pharmaceutical analytical standards
Amikacin
A semisynthetic aminoglycoside antibiotic made from kanamycin A, first described in 1972: it is given intravenously or intramuscularly for serious Gram-negative infections, including those resistant to other aminoglycosides. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Its side chain mirrors that of butirosin, an antibiotic made by the bacterium Bacillus circulans: it shields the molecule from many of the enzymes bacteria use to inactivate other aminoglycosides.
No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
